Cargando…
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations
Autores principales: | Benucci, Maurizio, Infantino, Maria, Manfredi, Mariangela, Li Gobbi, Francesca, Sarzi-Puttini, Piercarlo, Caproni, Marzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282441/ https://www.ncbi.nlm.nih.gov/pubmed/34274547 http://dx.doi.org/10.1016/j.autrev.2021.102908 |
Ejemplares similares
-
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021) -
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015) -
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011) -
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013) -
Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)